Pursuant to a special resolution passed by shareholders on Jan. 8, 2026, the company has consolidated its capital on a one-new-for-14-old basis. The name of the company has not been changed.

Effective at the opening on Sept. 2, 2026, the common shares of Neurothera Labs Inc. will commence trading on the TSX Venture Exchange on a consolidated basis. The company is classified as a technology company.

Postconsolidation

Capitalization:  unlimited shares with no par value, of which 13,724,571 shares are issued and outstanding

Escrow:  7,194,928 shares subject to escrow

Transfer agent:  Endeavor Trust Corp.

Trading symbol:  NTLX (unchanged)

Cusip No.:  64136J 20 0 (new)